Identifying T-Cell Receptors to Improve Cancer Immunotherapy
Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development.
This study is working on a new way to find and understand special immune cells that can target unique markers on cancer cells, with the hope of creating better and more personalized treatments for cancer patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Flexomics LLC NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project ID | NIH-10652632 on NIH RePORTER |
What this research studies
This research focuses on developing a new platform to identify and characterize T-cell receptors (TCRs) that specifically target neoantigens in cancer cells. By utilizing advanced techniques such as live cell analysis and single-cell genomics, the project aims to enhance the effectiveness of immunotherapy for cancer patients. The goal is to create a high-throughput method that can discover a wider range of TCRs, potentially providing more personalized treatment options for patients with various types of tumors. This innovative approach seeks to address the limitations of current therapies that often overlook less common mutations.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients whose tumors have unique neoantigens that are not currently targeted by existing therapies.
Not a fit: Patients with tumors that do not express neoantigens or those who are not eligible for immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized immunotherapy options for cancer patients, improving treatment outcomes.
How similar studies have performed: Other research has shown promise in using similar high-throughput methods to identify TCRs, indicating that this approach could be effective.
Where this research is happening
Waltham, United States
- Flexomics LLC — Waltham, United States (Active)
Researchers
- Principal investigator: Soumillon, Magali — Flexomics LLC
- Study coordinator: Soumillon, Magali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.